A small new study offers insight into plasma exchange therapy. By Mohana Ravindranath Cars need oil changes to keep their engines running smoothly. Some anti-aging influencers, along with a handful of ...
As many as four percent of the world’s population lives with an autoimmune disease, in which the immune system fails to distinguish between ‘self’ and ‘non-self’ and mistakenly attacks the body, ...
You might switch up your diet or pop a supplement in hopes of living longer. But would you pay thousands of dollars to replace the plasma in your blood? This procedure, known as plasma exchange ...
Plasma exchange therapy is gaining popularity as a wellness trend among longevity-seekers. The procedure involves replacing plasma to remove toxins, typically from specific health conditions. There's ...
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Takeda (TSE:4502/NYSE:TAK) today announced full results from the pivotal Phase 3 ADVANCE-CIDP 1 clinical trial investigating HYQVIA® [Immune Globulin ...
Takeda kicked off 2024 by reeling in an approval for HyQvia in chronic inflammatory demyelinating polyneuropathy (CIDP), and it’s closing out the year by launching its first direct-to-consumer ...
In 2014, Baxter got HyQvia over the FDA finish line for patients with primary immunodeficiency (PI). Eight years and three companies later, Takeda is finding more uses for the subcutaneous treatment.
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Gabby Landsverk Every time Gabby publishes a story, you’ll get an alert straight to your inbox!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback